NDAQ Sep 2024 57.500 call
| Previous Close | 6.70 |
| Open | 6.70 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 57.50 |
| Expire Date | 2024-09-20 |
| Day's Range | 6.70 - 6.70 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
IPO-Edge.comIPO Edge Fireside Chats at Nasdaq on June 11
IPO Edge will host fireside chats at Nasdaq MarketSite on Tuesday, June 11, 2024, from 2:00 pm until 3:00 pm at the state-of-the-art Studio A, home of the iconic daily […]
GlobeNewswireDelisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.’s securities were suspended on March 18, 2024, and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the ordinary shares and warrants of Tritium DCFC Limited. Tritium DCFC Limited’s securities were suspended on April 22, 2024, and have not traded on Nasdaq since that time. Nasdaq als
- GlobeNewswire
Nasdaq to Enhance Global Market Surveillance Offering with Generative AI
Nasdaq to integrate Gen AI feature into its leading market surveillance technology for regulators andmarketplaces globally AI functionality will improve overall quality and efficiency of market abuse investigations for our clients,enhancing integrity of the financial system NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the new AI powered feature within its Market Surveillance technology solution that will significantly enhance the quality, speed, and efficiency
